glp-1 agonist dpp 4 inhibitor Mechanism of action for GIP, analogues and DPP4 inhibitors in DPP-4 Inhibitors and the Quest

FDA Investigating Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas From Incretin Mimetic Drugs for Type 2 Diabetes

10.3389/fendo.2022.1043789 60 LoombaR.HartmanM

FDA approves Ozempic (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease [press release]

YanWCuiXGuoTLiuNWangZSunYet al

Medication will be administered by injecting into the fatty area on your stomach weekly

For myocardial infarction, GLP-1RAs alleviate and repair MI via SIRT1/Parkin/mitophagy, insulin-like growth factor-1/2 and upregulating -estrogen receptor